Middlemen have outsized influence on U.S. drug prices due to market consolidation, FTC says
Publishing timestamp: 2024-07-09 13:43:05
Summary
The FTC has found that the consolidation of pharmacies and health insurance companies has led to a few pharmacy benefit managers having too much influence over prescription drug prices in the US. The biggest PBMs are accused of inflating drug costs and squeezing smaller pharmacies and consumers, leading to a call for greater regulation. The report also highlights conflicts of interest and lack of transparency in the PBM market.
Sentiment: NEGATIVE
Keywords: business, business news, health care industry, cvs health corp, unitedhealth group inc, cigna corp, joe biden,